Rami Doukky to Kidney Failure, Chronic
This is a "connection" page, showing publications Rami Doukky has written about Kidney Failure, Chronic.
Connection Strength
5.825
-
Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation. J Nucl Cardiol. 2023 10; 30(5):1897-1903.
Score: 0.760
-
The prognostic and diagnostic implications of surveillance serial myocardial perfusion imaging in asymptomatic renal transplant candidates. J Nucl Cardiol. 2023 02; 30(1):152-163.
Score: 0.714
-
Cardiac imaging for the assessment of patients being evaluated for kidney transplantation. J Nucl Cardiol. 2022 04; 29(2):543-557.
Score: 0.653
-
The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date. J Nucl Cardiol. 2022 Feb; 29(1):101-110.
Score: 0.624
-
Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease. Clin Cardiol. 2018 May; 41(5):660-665.
Score: 0.537
-
The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2019 06; 26(3):814-822.
Score: 0.514
-
Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
Score: 0.506
-
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.
Score: 0.452
-
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016 06; 23(3):560-9.
Score: 0.445
-
The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
Score: 0.369
-
Intermittent pneumatic compression in patients with ESRD. A systematic review. Hemodial Int. 2019 10; 23(4):433-444.
Score: 0.146
-
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
Score: 0.106